Global Prefilled Injection Delivery Devices for GLP-1 Drugs Supply, Demand and Key Producers, 2026-2032
The global Prefilled Injection Delivery Devices for GLP-1 Drugs market size is expected to reach $ 7398 million by 2032, rising at a market growth of 13.2% CAGR during the forecast period (2026-2032).
Prefilled injection delivery devices for GLP-1 drugs are physical subcutaneous delivery products used for GLP-1 and related metabolic injectable therapies, including semaglutide, tirzepatide, liraglutide and dulaglutide. The research scope focuses on injection devices and core primary packaging combinations that integrate prefilled drug containment, dose control, sealing protection and patient self injection functions. Main product forms include disposable prefilled pen injectors, multi dose prefilled pen injectors, autoinjectors, prefillable syringes, cartridge based pen systems and safety injection components. Key manufacturing processes include medical grade polymer injection molding, glass or cyclic olefin polymer syringe forming, siliconization, precision spring and drive mechanism assembly, dose setting mechanism design, sterile barrier control, low extractable primary packaging treatment, automated assembly and terminal sterilization validation. Key specifications include fill volume, dose accuracy, activation force, injection time, container closure integrity, extractables and leachables profile, particulate control, needlestick safety and patient usability. Their core function is to improve convenience, safety, adherence and commercial scale up capability for long term GLP-1 self injection therapy, mainly used in diabetes treatment, obesity treatment, weight management and metabolic syndrome management. In 2025, the global average ex factory price was about USD 3.10 per set, and the industry average gross margin was about 32%.
Prefilled injection delivery devices for GLP-1 drugs are becoming a critical physical supply chain segment behind the rapid expansion of injectable metabolic therapies. The upstream base consists of medical glass, cyclic olefin polymers, elastomeric closures, needles, springs, silicone oil, precision molded components and automated assembly equipment. The midstream layer covers prefilled pen injectors, autoinjectors, prefillable syringes and cartridge based pen systems. The downstream demand comes mainly from diabetes, obesity, weight management and metabolic disease therapies. As GLP-1 therapies move from specialist treatment into long term self administration, the delivery device is no longer a passive container. It directly affects patient adherence, dosing safety, user experience and the ability of drug companies to scale commercial supply. The competitive structure is concentrated among companies with validated manufacturing systems, drug packaging expertise, device design capability and long term pharmaceutical customer relationships. Europe, the United States and Japan remain strong in high end prefilled systems, autoinjector platforms, primary packaging validation and global supply qualification. Chinese manufacturers are expanding from prefillable syringes, pen injector components and automatic injection pens, but the commercial GLP-1 supply chain still requires stronger evidence of customer qualification and large scale output. Capital expenditure is rising across the industry, with new plants, additional assembly lines and regionalized supply chain projects responding to the need for secure device availability. The policy environment supports safer and more convenient self injection, while regulatory requirements continue to raise entry barriers. These products must meet expectations for pharmaceutical packaging, medical device quality systems, sterile manufacturing, human factors engineering and combination product compliance. Future growth will be driven by wider GLP-1 indications, broader obesity treatment adoption, higher self injection penetration and emerging market demand. However, the industry also faces risks from oral GLP-1 alternatives, longer acting formulations, multi dose formats, pricing pressure and device standardization. Overall, the sector remains in a high growth phase, but long term competitiveness will depend on platform design, validated scale manufacturing, automation and global supply reliability.
This report studies the global Prefilled Injection Delivery Devices for GLP-1 Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prefilled Injection Delivery Devices for GLP-1 Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prefilled Injection Delivery Devices for GLP-1 Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prefilled Injection Delivery Devices for GLP-1 Drugs total production and demand, 2021-2032, (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs total production value, 2021-2032, (USD Million)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Unit), (based on production site)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs consumption by region & country, CAGR, 2021-2032 & (Unit)
U.S. VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs domestic production, consumption, key domestic manufacturers and share
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
This report profiles key players in the global Prefilled Injection Delivery Devices for GLP-1 Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ypsomed Holding AG, SHL Medical AG, Gerresheimer AG, SCHOTT Pharma AG & Co. KGaA, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Phillips-Medisize, Nemera, Haselmeier GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prefilled Injection Delivery Devices for GLP-1 Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Unit) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prefilled Injection Delivery Devices for GLP-1 Drugs Market, By Region:
1. How big is the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
2. What is the demand of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
3. What is the year over year growth of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
4. What is the production and production value of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
5. Who are the key producers in the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
6. What are the growth factors driving the market demand?
Prefilled injection delivery devices for GLP-1 drugs are physical subcutaneous delivery products used for GLP-1 and related metabolic injectable therapies, including semaglutide, tirzepatide, liraglutide and dulaglutide. The research scope focuses on injection devices and core primary packaging combinations that integrate prefilled drug containment, dose control, sealing protection and patient self injection functions. Main product forms include disposable prefilled pen injectors, multi dose prefilled pen injectors, autoinjectors, prefillable syringes, cartridge based pen systems and safety injection components. Key manufacturing processes include medical grade polymer injection molding, glass or cyclic olefin polymer syringe forming, siliconization, precision spring and drive mechanism assembly, dose setting mechanism design, sterile barrier control, low extractable primary packaging treatment, automated assembly and terminal sterilization validation. Key specifications include fill volume, dose accuracy, activation force, injection time, container closure integrity, extractables and leachables profile, particulate control, needlestick safety and patient usability. Their core function is to improve convenience, safety, adherence and commercial scale up capability for long term GLP-1 self injection therapy, mainly used in diabetes treatment, obesity treatment, weight management and metabolic syndrome management. In 2025, the global average ex factory price was about USD 3.10 per set, and the industry average gross margin was about 32%.
Prefilled injection delivery devices for GLP-1 drugs are becoming a critical physical supply chain segment behind the rapid expansion of injectable metabolic therapies. The upstream base consists of medical glass, cyclic olefin polymers, elastomeric closures, needles, springs, silicone oil, precision molded components and automated assembly equipment. The midstream layer covers prefilled pen injectors, autoinjectors, prefillable syringes and cartridge based pen systems. The downstream demand comes mainly from diabetes, obesity, weight management and metabolic disease therapies. As GLP-1 therapies move from specialist treatment into long term self administration, the delivery device is no longer a passive container. It directly affects patient adherence, dosing safety, user experience and the ability of drug companies to scale commercial supply. The competitive structure is concentrated among companies with validated manufacturing systems, drug packaging expertise, device design capability and long term pharmaceutical customer relationships. Europe, the United States and Japan remain strong in high end prefilled systems, autoinjector platforms, primary packaging validation and global supply qualification. Chinese manufacturers are expanding from prefillable syringes, pen injector components and automatic injection pens, but the commercial GLP-1 supply chain still requires stronger evidence of customer qualification and large scale output. Capital expenditure is rising across the industry, with new plants, additional assembly lines and regionalized supply chain projects responding to the need for secure device availability. The policy environment supports safer and more convenient self injection, while regulatory requirements continue to raise entry barriers. These products must meet expectations for pharmaceutical packaging, medical device quality systems, sterile manufacturing, human factors engineering and combination product compliance. Future growth will be driven by wider GLP-1 indications, broader obesity treatment adoption, higher self injection penetration and emerging market demand. However, the industry also faces risks from oral GLP-1 alternatives, longer acting formulations, multi dose formats, pricing pressure and device standardization. Overall, the sector remains in a high growth phase, but long term competitiveness will depend on platform design, validated scale manufacturing, automation and global supply reliability.
This report studies the global Prefilled Injection Delivery Devices for GLP-1 Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prefilled Injection Delivery Devices for GLP-1 Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prefilled Injection Delivery Devices for GLP-1 Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prefilled Injection Delivery Devices for GLP-1 Drugs total production and demand, 2021-2032, (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs total production value, 2021-2032, (USD Million)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Unit), (based on production site)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs consumption by region & country, CAGR, 2021-2032 & (Unit)
U.S. VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs domestic production, consumption, key domestic manufacturers and share
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
Global Prefilled Injection Delivery Devices for GLP-1 Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Unit)
This report profiles key players in the global Prefilled Injection Delivery Devices for GLP-1 Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ypsomed Holding AG, SHL Medical AG, Gerresheimer AG, SCHOTT Pharma AG & Co. KGaA, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Phillips-Medisize, Nemera, Haselmeier GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prefilled Injection Delivery Devices for GLP-1 Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Unit) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prefilled Injection Delivery Devices for GLP-1 Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prefilled Pen Injector
- Autoinjector
- Prefillable Syringe
- Cartridge based Pen System
- Safety Injection Component
- Others
- Single dose Device
- Multi dose Device
- Others
- Type 2 Diabetes Treatment
- Obesity Treatment
- Cardiometabolic Risk Management
- Other Metabolic Disorders
- Hospital
- Pharmacy
- Others
- Ypsomed Holding AG
- SHL Medical AG
- Gerresheimer AG
- SCHOTT Pharma AG & Co. KGaA
- Stevanato Group S.p.A.
- West Pharmaceutical Services, Inc.
- Becton, Dickinson and Company
- Phillips-Medisize
- Nemera
- Haselmeier GmbH
- Owen Mumford Ltd.
- Terumo Corporation
- Nipro Corporation
- Bespak
- Credence MedSystems, Inc.
- Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd.
- Wuxi NEST Life Sciences Co., Ltd.
- Jiangsu Wanhai Medical Instrument Co., Ltd.
1. How big is the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
2. What is the demand of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
3. What is the year over year growth of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
4. What is the production and production value of the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
5. Who are the key producers in the global Prefilled Injection Delivery Devices for GLP-1 Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Introduction
1.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Supply & Forecast
1.2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.2.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Pricing Trends (2021-2032)
1.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (Based on Production Site)
1.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021-2032)
1.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2021-2032)
1.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2021-2032)
1.3.4 North America Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.5 Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.6 China Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.7 Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Prefilled Injection Delivery Devices for GLP-1 Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Demand (2021-2032)
2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region
2.2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region (2021-2026)
2.2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.4 China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.5 Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.6 Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.7 South Korea Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.8 ASEAN Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.9 India Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Manufacturer (2021-2026)
3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Manufacturer (2021-2026)
3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Manufacturer (2021-2026)
3.4 Prefilled Injection Delivery Devices for GLP-1 Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Prefilled Injection Delivery Devices for GLP-1 Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Prefilled Injection Delivery Devices for GLP-1 Drugs in 2025
3.6 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Overall Company Footprint Analysis
3.6.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Region Footprint
3.6.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Type Footprint
3.6.3 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison
4.1.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison
4.2.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison
4.3.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
4.5 China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share
4.5.1 China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
4.6 Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Prefilled Pen Injector
5.2.2 Autoinjector
5.2.3 Prefillable Syringe
5.2.4 Cartridge based Pen System
5.2.5 Safety Injection Component
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2021-2032)
5.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2021-2032)
5.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSE FORMAT
6.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Dose Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dose Format
6.2.1 Single dose Device
6.2.2 Multi dose Device
6.2.3 Others
6.3 Market Segment by Dose Format
6.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2021-2032)
6.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2021-2032)
6.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2032)
7 MARKET ANALYSIS BY INDICATION
7.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Indication
7.2.1 Type 2 Diabetes Treatment
7.2.2 Obesity Treatment
7.2.3 Cardiometabolic Risk Management
7.2.4 Other Metabolic Disorders
7.3 Market Segment by Indication
7.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2021-2032)
7.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2021-2032)
7.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Pharmacy
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2021-2032)
8.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2021-2032)
8.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Ypsomed Holding AG
9.1.1 Ypsomed Holding AG Details
9.1.2 Ypsomed Holding AG Major Business
9.1.3 Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.1.4 Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Ypsomed Holding AG Recent Developments/Updates
9.1.6 Ypsomed Holding AG Competitive Strengths & Weaknesses
9.2 SHL Medical AG
9.2.1 SHL Medical AG Details
9.2.2 SHL Medical AG Major Business
9.2.3 SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.2.4 SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 SHL Medical AG Recent Developments/Updates
9.2.6 SHL Medical AG Competitive Strengths & Weaknesses
9.3 Gerresheimer AG
9.3.1 Gerresheimer AG Details
9.3.2 Gerresheimer AG Major Business
9.3.3 Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.3.4 Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Gerresheimer AG Recent Developments/Updates
9.3.6 Gerresheimer AG Competitive Strengths & Weaknesses
9.4 SCHOTT Pharma AG & Co. KGaA
9.4.1 SCHOTT Pharma AG & Co. KGaA Details
9.4.2 SCHOTT Pharma AG & Co. KGaA Major Business
9.4.3 SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.4.4 SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 SCHOTT Pharma AG & Co. KGaA Recent Developments/Updates
9.4.6 SCHOTT Pharma AG & Co. KGaA Competitive Strengths & Weaknesses
9.5 Stevanato Group S.p.A.
9.5.1 Stevanato Group S.p.A. Details
9.5.2 Stevanato Group S.p.A. Major Business
9.5.3 Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.5.4 Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Stevanato Group S.p.A. Recent Developments/Updates
9.5.6 Stevanato Group S.p.A. Competitive Strengths & Weaknesses
9.6 West Pharmaceutical Services, Inc.
9.6.1 West Pharmaceutical Services, Inc. Details
9.6.2 West Pharmaceutical Services, Inc. Major Business
9.6.3 West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.6.4 West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
9.6.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
9.7 Becton, Dickinson and Company
9.7.1 Becton, Dickinson and Company Details
9.7.2 Becton, Dickinson and Company Major Business
9.7.3 Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.7.4 Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Becton, Dickinson and Company Recent Developments/Updates
9.7.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
9.8 Phillips-Medisize
9.8.1 Phillips-Medisize Details
9.8.2 Phillips-Medisize Major Business
9.8.3 Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.8.4 Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Phillips-Medisize Recent Developments/Updates
9.8.6 Phillips-Medisize Competitive Strengths & Weaknesses
9.9 Nemera
9.9.1 Nemera Details
9.9.2 Nemera Major Business
9.9.3 Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.9.4 Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nemera Recent Developments/Updates
9.9.6 Nemera Competitive Strengths & Weaknesses
9.10 Haselmeier GmbH
9.10.1 Haselmeier GmbH Details
9.10.2 Haselmeier GmbH Major Business
9.10.3 Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.10.4 Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Haselmeier GmbH Recent Developments/Updates
9.10.6 Haselmeier GmbH Competitive Strengths & Weaknesses
9.11 Owen Mumford Ltd.
9.11.1 Owen Mumford Ltd. Details
9.11.2 Owen Mumford Ltd. Major Business
9.11.3 Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.11.4 Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Owen Mumford Ltd. Recent Developments/Updates
9.11.6 Owen Mumford Ltd. Competitive Strengths & Weaknesses
9.12 Terumo Corporation
9.12.1 Terumo Corporation Details
9.12.2 Terumo Corporation Major Business
9.12.3 Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.12.4 Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Terumo Corporation Recent Developments/Updates
9.12.6 Terumo Corporation Competitive Strengths & Weaknesses
9.13 Nipro Corporation
9.13.1 Nipro Corporation Details
9.13.2 Nipro Corporation Major Business
9.13.3 Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.13.4 Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Nipro Corporation Recent Developments/Updates
9.13.6 Nipro Corporation Competitive Strengths & Weaknesses
9.14 Bespak
9.14.1 Bespak Details
9.14.2 Bespak Major Business
9.14.3 Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.14.4 Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Bespak Recent Developments/Updates
9.14.6 Bespak Competitive Strengths & Weaknesses
9.15 Credence MedSystems, Inc.
9.15.1 Credence MedSystems, Inc. Details
9.15.2 Credence MedSystems, Inc. Major Business
9.15.3 Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.15.4 Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Credence MedSystems, Inc. Recent Developments/Updates
9.15.6 Credence MedSystems, Inc. Competitive Strengths & Weaknesses
9.16 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd.
9.16.1 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Details
9.16.2 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Major Business
9.16.3 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.16.4 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Recent Developments/Updates
9.16.6 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Competitive Strengths & Weaknesses
9.17 Wuxi NEST Life Sciences Co., Ltd.
9.17.1 Wuxi NEST Life Sciences Co., Ltd. Details
9.17.2 Wuxi NEST Life Sciences Co., Ltd. Major Business
9.17.3 Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.17.4 Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Wuxi NEST Life Sciences Co., Ltd. Recent Developments/Updates
9.17.6 Wuxi NEST Life Sciences Co., Ltd. Competitive Strengths & Weaknesses
9.18 Jiangsu Wanhai Medical Instrument Co., Ltd.
9.18.1 Jiangsu Wanhai Medical Instrument Co., Ltd. Details
9.18.2 Jiangsu Wanhai Medical Instrument Co., Ltd. Major Business
9.18.3 Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.18.4 Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Jiangsu Wanhai Medical Instrument Co., Ltd. Recent Developments/Updates
9.18.6 Jiangsu Wanhai Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Chain
10.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Upstream Analysis
10.2.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Core Raw Materials
10.2.2 Main Manufacturers of Prefilled Injection Delivery Devices for GLP-1 Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Prefilled Injection Delivery Devices for GLP-1 Drugs Production Mode
10.6 Prefilled Injection Delivery Devices for GLP-1 Drugs Procurement Model
10.7 Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Sales Model and Sales Channels
10.7.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Model
10.7.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Introduction
1.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Supply & Forecast
1.2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.2.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Pricing Trends (2021-2032)
1.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (Based on Production Site)
1.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021-2032)
1.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2021-2032)
1.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2021-2032)
1.3.4 North America Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.5 Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.6 China Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.3.7 Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Prefilled Injection Delivery Devices for GLP-1 Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Demand (2021-2032)
2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region
2.2.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region (2021-2026)
2.2.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.4 China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.5 Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.6 Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.7 South Korea Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.8 ASEAN Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
2.9 India Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Manufacturer (2021-2026)
3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Manufacturer (2021-2026)
3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Manufacturer (2021-2026)
3.4 Prefilled Injection Delivery Devices for GLP-1 Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Prefilled Injection Delivery Devices for GLP-1 Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Prefilled Injection Delivery Devices for GLP-1 Drugs in 2025
3.6 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Overall Company Footprint Analysis
3.6.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Region Footprint
3.6.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Type Footprint
3.6.3 Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison
4.1.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison
4.2.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison
4.3.1 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
4.5 China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share
4.5.1 China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
4.6 Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Prefilled Pen Injector
5.2.2 Autoinjector
5.2.3 Prefillable Syringe
5.2.4 Cartridge based Pen System
5.2.5 Safety Injection Component
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2021-2032)
5.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2021-2032)
5.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSE FORMAT
6.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Dose Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dose Format
6.2.1 Single dose Device
6.2.2 Multi dose Device
6.2.3 Others
6.3 Market Segment by Dose Format
6.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2021-2032)
6.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2021-2032)
6.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2032)
7 MARKET ANALYSIS BY INDICATION
7.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Indication
7.2.1 Type 2 Diabetes Treatment
7.2.2 Obesity Treatment
7.2.3 Cardiometabolic Risk Management
7.2.4 Other Metabolic Disorders
7.3 Market Segment by Indication
7.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2021-2032)
7.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2021-2032)
7.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Pharmacy
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2021-2032)
8.3.2 World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2021-2032)
8.3.3 World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Ypsomed Holding AG
9.1.1 Ypsomed Holding AG Details
9.1.2 Ypsomed Holding AG Major Business
9.1.3 Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.1.4 Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Ypsomed Holding AG Recent Developments/Updates
9.1.6 Ypsomed Holding AG Competitive Strengths & Weaknesses
9.2 SHL Medical AG
9.2.1 SHL Medical AG Details
9.2.2 SHL Medical AG Major Business
9.2.3 SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.2.4 SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 SHL Medical AG Recent Developments/Updates
9.2.6 SHL Medical AG Competitive Strengths & Weaknesses
9.3 Gerresheimer AG
9.3.1 Gerresheimer AG Details
9.3.2 Gerresheimer AG Major Business
9.3.3 Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.3.4 Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Gerresheimer AG Recent Developments/Updates
9.3.6 Gerresheimer AG Competitive Strengths & Weaknesses
9.4 SCHOTT Pharma AG & Co. KGaA
9.4.1 SCHOTT Pharma AG & Co. KGaA Details
9.4.2 SCHOTT Pharma AG & Co. KGaA Major Business
9.4.3 SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.4.4 SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 SCHOTT Pharma AG & Co. KGaA Recent Developments/Updates
9.4.6 SCHOTT Pharma AG & Co. KGaA Competitive Strengths & Weaknesses
9.5 Stevanato Group S.p.A.
9.5.1 Stevanato Group S.p.A. Details
9.5.2 Stevanato Group S.p.A. Major Business
9.5.3 Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.5.4 Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Stevanato Group S.p.A. Recent Developments/Updates
9.5.6 Stevanato Group S.p.A. Competitive Strengths & Weaknesses
9.6 West Pharmaceutical Services, Inc.
9.6.1 West Pharmaceutical Services, Inc. Details
9.6.2 West Pharmaceutical Services, Inc. Major Business
9.6.3 West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.6.4 West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
9.6.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
9.7 Becton, Dickinson and Company
9.7.1 Becton, Dickinson and Company Details
9.7.2 Becton, Dickinson and Company Major Business
9.7.3 Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.7.4 Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Becton, Dickinson and Company Recent Developments/Updates
9.7.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
9.8 Phillips-Medisize
9.8.1 Phillips-Medisize Details
9.8.2 Phillips-Medisize Major Business
9.8.3 Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.8.4 Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Phillips-Medisize Recent Developments/Updates
9.8.6 Phillips-Medisize Competitive Strengths & Weaknesses
9.9 Nemera
9.9.1 Nemera Details
9.9.2 Nemera Major Business
9.9.3 Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.9.4 Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nemera Recent Developments/Updates
9.9.6 Nemera Competitive Strengths & Weaknesses
9.10 Haselmeier GmbH
9.10.1 Haselmeier GmbH Details
9.10.2 Haselmeier GmbH Major Business
9.10.3 Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.10.4 Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Haselmeier GmbH Recent Developments/Updates
9.10.6 Haselmeier GmbH Competitive Strengths & Weaknesses
9.11 Owen Mumford Ltd.
9.11.1 Owen Mumford Ltd. Details
9.11.2 Owen Mumford Ltd. Major Business
9.11.3 Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.11.4 Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Owen Mumford Ltd. Recent Developments/Updates
9.11.6 Owen Mumford Ltd. Competitive Strengths & Weaknesses
9.12 Terumo Corporation
9.12.1 Terumo Corporation Details
9.12.2 Terumo Corporation Major Business
9.12.3 Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.12.4 Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Terumo Corporation Recent Developments/Updates
9.12.6 Terumo Corporation Competitive Strengths & Weaknesses
9.13 Nipro Corporation
9.13.1 Nipro Corporation Details
9.13.2 Nipro Corporation Major Business
9.13.3 Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.13.4 Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Nipro Corporation Recent Developments/Updates
9.13.6 Nipro Corporation Competitive Strengths & Weaknesses
9.14 Bespak
9.14.1 Bespak Details
9.14.2 Bespak Major Business
9.14.3 Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.14.4 Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Bespak Recent Developments/Updates
9.14.6 Bespak Competitive Strengths & Weaknesses
9.15 Credence MedSystems, Inc.
9.15.1 Credence MedSystems, Inc. Details
9.15.2 Credence MedSystems, Inc. Major Business
9.15.3 Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.15.4 Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Credence MedSystems, Inc. Recent Developments/Updates
9.15.6 Credence MedSystems, Inc. Competitive Strengths & Weaknesses
9.16 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd.
9.16.1 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Details
9.16.2 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Major Business
9.16.3 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.16.4 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Recent Developments/Updates
9.16.6 Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Competitive Strengths & Weaknesses
9.17 Wuxi NEST Life Sciences Co., Ltd.
9.17.1 Wuxi NEST Life Sciences Co., Ltd. Details
9.17.2 Wuxi NEST Life Sciences Co., Ltd. Major Business
9.17.3 Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.17.4 Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Wuxi NEST Life Sciences Co., Ltd. Recent Developments/Updates
9.17.6 Wuxi NEST Life Sciences Co., Ltd. Competitive Strengths & Weaknesses
9.18 Jiangsu Wanhai Medical Instrument Co., Ltd.
9.18.1 Jiangsu Wanhai Medical Instrument Co., Ltd. Details
9.18.2 Jiangsu Wanhai Medical Instrument Co., Ltd. Major Business
9.18.3 Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
9.18.4 Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Jiangsu Wanhai Medical Instrument Co., Ltd. Recent Developments/Updates
9.18.6 Jiangsu Wanhai Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Chain
10.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Upstream Analysis
10.2.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Core Raw Materials
10.2.2 Main Manufacturers of Prefilled Injection Delivery Devices for GLP-1 Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Prefilled Injection Delivery Devices for GLP-1 Drugs Production Mode
10.6 Prefilled Injection Delivery Devices for GLP-1 Drugs Procurement Model
10.7 Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Sales Model and Sales Channels
10.7.1 Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Model
10.7.2 Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2021-2026) & (Unit)
Table 7. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2027-2032) & (Unit)
Table 8. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2021-2026)
Table 9. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2027-2032)
Table 10. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Prefilled Injection Delivery Devices for GLP-1 Drugs Major Market Trends
Table 13. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Unit)
Table 14. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region (2021-2026) & (Unit)
Table 15. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Forecast by Region (2027-2032) & (Unit)
Table 16. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Prefilled Injection Delivery Devices for GLP-1 Drugs Producers in 2025
Table 18. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Manufacturer (2021-2026) & (Unit)
Table 19. Production Market Share of Key Prefilled Injection Delivery Devices for GLP-1 Drugs Producers in 2025
Table 20. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Prefilled Injection Delivery Devices for GLP-1 Drugs Company Evaluation Quadrant
Table 22. World Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Prefilled Injection Delivery Devices for GLP-1 Drugs Production Site of Key Manufacturer
Table 24. Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Type Footprint
Table 25. Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Application Footprint
Table 26. Prefilled Injection Delivery Devices for GLP-1 Drugs Competitive Factors
Table 27. Prefilled Injection Delivery Devices for GLP-1 Drugs New Entrant and Capacity Expansion Plans
Table 28. Prefilled Injection Delivery Devices for GLP-1 Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison, (2021 & 2025 & 2032) & (Unit)
Table 31. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison, (2021 & 2025 & 2032) & (Unit)
Table 32. United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026) & (Unit)
Table 36. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 37. China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production, (2021-2026) & (Unit)
Table 41. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production, (2021-2026) & (Unit)
Table 46. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 47. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2021-2026) & (Unit)
Table 49. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2027-2032) & (Unit)
Table 50. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format, (USD Million), 2021 & 2025 & 2032
Table 55. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2021-2026) & (Unit)
Table 56. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2027-2032) & (Unit)
Table 57. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2021-2026) & (USD Million)
Table 58. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2027-2032) & (USD Million)
Table 59. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2026) & (US$/Unit)
Table 60. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2027-2032) & (US$/Unit)
Table 61. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2021-2026) & (Unit)
Table 63. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2027-2032) & (Unit)
Table 64. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2021-2026) & (USD Million)
Table 65. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2027-2032) & (USD Million)
Table 66. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2026) & (US$/Unit)
Table 67. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2027-2032) & (US$/Unit)
Table 68. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2021-2026) & (Unit)
Table 70. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2027-2032) & (Unit)
Table 71. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Ypsomed Holding AG Basic Information, Manufacturing Base and Competitors
Table 76. Ypsomed Holding AG Major Business
Table 77. Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 78. Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Ypsomed Holding AG Recent Developments/Updates
Table 80. Ypsomed Holding AG Competitive Strengths & Weaknesses
Table 81. SHL Medical AG Basic Information, Manufacturing Base and Competitors
Table 82. SHL Medical AG Major Business
Table 83. SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 84. SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. SHL Medical AG Recent Developments/Updates
Table 86. SHL Medical AG Competitive Strengths & Weaknesses
Table 87. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 88. Gerresheimer AG Major Business
Table 89. Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 90. Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Gerresheimer AG Recent Developments/Updates
Table 92. Gerresheimer AG Competitive Strengths & Weaknesses
Table 93. SCHOTT Pharma AG & Co. KGaA Basic Information, Manufacturing Base and Competitors
Table 94. SCHOTT Pharma AG & Co. KGaA Major Business
Table 95. SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 96. SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. SCHOTT Pharma AG & Co. KGaA Recent Developments/Updates
Table 98. SCHOTT Pharma AG & Co. KGaA Competitive Strengths & Weaknesses
Table 99. Stevanato Group S.p.A. Basic Information, Manufacturing Base and Competitors
Table 100. Stevanato Group S.p.A. Major Business
Table 101. Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 102. Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Stevanato Group S.p.A. Recent Developments/Updates
Table 104. Stevanato Group S.p.A. Competitive Strengths & Weaknesses
Table 105. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 106. West Pharmaceutical Services, Inc. Major Business
Table 107. West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 108. West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 110. West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
Table 111. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 112. Becton, Dickinson and Company Major Business
Table 113. Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 114. Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Becton, Dickinson and Company Recent Developments/Updates
Table 116. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 117. Phillips-Medisize Basic Information, Manufacturing Base and Competitors
Table 118. Phillips-Medisize Major Business
Table 119. Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 120. Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Phillips-Medisize Recent Developments/Updates
Table 122. Phillips-Medisize Competitive Strengths & Weaknesses
Table 123. Nemera Basic Information, Manufacturing Base and Competitors
Table 124. Nemera Major Business
Table 125. Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 126. Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nemera Recent Developments/Updates
Table 128. Nemera Competitive Strengths & Weaknesses
Table 129. Haselmeier GmbH Basic Information, Manufacturing Base and Competitors
Table 130. Haselmeier GmbH Major Business
Table 131. Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 132. Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Haselmeier GmbH Recent Developments/Updates
Table 134. Haselmeier GmbH Competitive Strengths & Weaknesses
Table 135. Owen Mumford Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Owen Mumford Ltd. Major Business
Table 137. Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 138. Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Owen Mumford Ltd. Recent Developments/Updates
Table 140. Owen Mumford Ltd. Competitive Strengths & Weaknesses
Table 141. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 142. Terumo Corporation Major Business
Table 143. Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 144. Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Terumo Corporation Recent Developments/Updates
Table 146. Terumo Corporation Competitive Strengths & Weaknesses
Table 147. Nipro Corporation Basic Information, Manufacturing Base and Competitors
Table 148. Nipro Corporation Major Business
Table 149. Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 150. Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Nipro Corporation Recent Developments/Updates
Table 152. Nipro Corporation Competitive Strengths & Weaknesses
Table 153. Bespak Basic Information, Manufacturing Base and Competitors
Table 154. Bespak Major Business
Table 155. Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 156. Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Bespak Recent Developments/Updates
Table 158. Bespak Competitive Strengths & Weaknesses
Table 159. Credence MedSystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 160. Credence MedSystems, Inc. Major Business
Table 161. Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 162. Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Credence MedSystems, Inc. Recent Developments/Updates
Table 164. Credence MedSystems, Inc. Competitive Strengths & Weaknesses
Table 165. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Major Business
Table 167. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 168. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Recent Developments/Updates
Table 170. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Wuxi NEST Life Sciences Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Wuxi NEST Life Sciences Co., Ltd. Major Business
Table 173. Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 174. Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Wuxi NEST Life Sciences Co., Ltd. Recent Developments/Updates
Table 176. Wuxi NEST Life Sciences Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Jiangsu Wanhai Medical Instrument Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 178. Jiangsu Wanhai Medical Instrument Co., Ltd. Major Business
Table 179. Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 180. Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Jiangsu Wanhai Medical Instrument Co., Ltd. Recent Developments/Updates
Table 182. Jiangsu Wanhai Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
Table 183. Global Key Players of Prefilled Injection Delivery Devices for GLP-1 Drugs Upstream (Raw Materials)
Table 184. Global Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Customers
Table 185. Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Distributors
Table 1. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2021-2026) & (Unit)
Table 7. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Region (2027-2032) & (Unit)
Table 8. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2021-2026)
Table 9. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2027-2032)
Table 10. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Prefilled Injection Delivery Devices for GLP-1 Drugs Major Market Trends
Table 13. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Unit)
Table 14. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption by Region (2021-2026) & (Unit)
Table 15. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Forecast by Region (2027-2032) & (Unit)
Table 16. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Prefilled Injection Delivery Devices for GLP-1 Drugs Producers in 2025
Table 18. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Manufacturer (2021-2026) & (Unit)
Table 19. Production Market Share of Key Prefilled Injection Delivery Devices for GLP-1 Drugs Producers in 2025
Table 20. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Prefilled Injection Delivery Devices for GLP-1 Drugs Company Evaluation Quadrant
Table 22. World Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Prefilled Injection Delivery Devices for GLP-1 Drugs Production Site of Key Manufacturer
Table 24. Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Type Footprint
Table 25. Prefilled Injection Delivery Devices for GLP-1 Drugs Market: Company Product Application Footprint
Table 26. Prefilled Injection Delivery Devices for GLP-1 Drugs Competitive Factors
Table 27. Prefilled Injection Delivery Devices for GLP-1 Drugs New Entrant and Capacity Expansion Plans
Table 28. Prefilled Injection Delivery Devices for GLP-1 Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Production Comparison, (2021 & 2025 & 2032) & (Unit)
Table 31. United States VS China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Comparison, (2021 & 2025 & 2032) & (Unit)
Table 32. United States Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2026) & (Unit)
Table 36. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 37. China Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production, (2021-2026) & (Unit)
Table 41. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Prefilled Injection Delivery Devices for GLP-1 Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production, (2021-2026) & (Unit)
Table 46. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share (2021-2026)
Table 47. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2021-2026) & (Unit)
Table 49. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Type (2027-2032) & (Unit)
Table 50. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format, (USD Million), 2021 & 2025 & 2032
Table 55. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2021-2026) & (Unit)
Table 56. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Dose Format (2027-2032) & (Unit)
Table 57. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2021-2026) & (USD Million)
Table 58. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format (2027-2032) & (USD Million)
Table 59. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2026) & (US$/Unit)
Table 60. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2027-2032) & (US$/Unit)
Table 61. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2021-2026) & (Unit)
Table 63. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Indication (2027-2032) & (Unit)
Table 64. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2021-2026) & (USD Million)
Table 65. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication (2027-2032) & (USD Million)
Table 66. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2026) & (US$/Unit)
Table 67. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2027-2032) & (US$/Unit)
Table 68. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2021-2026) & (Unit)
Table 70. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production by Application (2027-2032) & (Unit)
Table 71. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Ypsomed Holding AG Basic Information, Manufacturing Base and Competitors
Table 76. Ypsomed Holding AG Major Business
Table 77. Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 78. Ypsomed Holding AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Ypsomed Holding AG Recent Developments/Updates
Table 80. Ypsomed Holding AG Competitive Strengths & Weaknesses
Table 81. SHL Medical AG Basic Information, Manufacturing Base and Competitors
Table 82. SHL Medical AG Major Business
Table 83. SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 84. SHL Medical AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. SHL Medical AG Recent Developments/Updates
Table 86. SHL Medical AG Competitive Strengths & Weaknesses
Table 87. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 88. Gerresheimer AG Major Business
Table 89. Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 90. Gerresheimer AG Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Gerresheimer AG Recent Developments/Updates
Table 92. Gerresheimer AG Competitive Strengths & Weaknesses
Table 93. SCHOTT Pharma AG & Co. KGaA Basic Information, Manufacturing Base and Competitors
Table 94. SCHOTT Pharma AG & Co. KGaA Major Business
Table 95. SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 96. SCHOTT Pharma AG & Co. KGaA Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. SCHOTT Pharma AG & Co. KGaA Recent Developments/Updates
Table 98. SCHOTT Pharma AG & Co. KGaA Competitive Strengths & Weaknesses
Table 99. Stevanato Group S.p.A. Basic Information, Manufacturing Base and Competitors
Table 100. Stevanato Group S.p.A. Major Business
Table 101. Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 102. Stevanato Group S.p.A. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Stevanato Group S.p.A. Recent Developments/Updates
Table 104. Stevanato Group S.p.A. Competitive Strengths & Weaknesses
Table 105. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 106. West Pharmaceutical Services, Inc. Major Business
Table 107. West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 108. West Pharmaceutical Services, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 110. West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
Table 111. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 112. Becton, Dickinson and Company Major Business
Table 113. Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 114. Becton, Dickinson and Company Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Becton, Dickinson and Company Recent Developments/Updates
Table 116. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 117. Phillips-Medisize Basic Information, Manufacturing Base and Competitors
Table 118. Phillips-Medisize Major Business
Table 119. Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 120. Phillips-Medisize Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Phillips-Medisize Recent Developments/Updates
Table 122. Phillips-Medisize Competitive Strengths & Weaknesses
Table 123. Nemera Basic Information, Manufacturing Base and Competitors
Table 124. Nemera Major Business
Table 125. Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 126. Nemera Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nemera Recent Developments/Updates
Table 128. Nemera Competitive Strengths & Weaknesses
Table 129. Haselmeier GmbH Basic Information, Manufacturing Base and Competitors
Table 130. Haselmeier GmbH Major Business
Table 131. Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 132. Haselmeier GmbH Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Haselmeier GmbH Recent Developments/Updates
Table 134. Haselmeier GmbH Competitive Strengths & Weaknesses
Table 135. Owen Mumford Ltd. Basic Information, Manufacturing Base and Competitors
Table 136. Owen Mumford Ltd. Major Business
Table 137. Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 138. Owen Mumford Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Owen Mumford Ltd. Recent Developments/Updates
Table 140. Owen Mumford Ltd. Competitive Strengths & Weaknesses
Table 141. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 142. Terumo Corporation Major Business
Table 143. Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 144. Terumo Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Terumo Corporation Recent Developments/Updates
Table 146. Terumo Corporation Competitive Strengths & Weaknesses
Table 147. Nipro Corporation Basic Information, Manufacturing Base and Competitors
Table 148. Nipro Corporation Major Business
Table 149. Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 150. Nipro Corporation Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Nipro Corporation Recent Developments/Updates
Table 152. Nipro Corporation Competitive Strengths & Weaknesses
Table 153. Bespak Basic Information, Manufacturing Base and Competitors
Table 154. Bespak Major Business
Table 155. Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 156. Bespak Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Bespak Recent Developments/Updates
Table 158. Bespak Competitive Strengths & Weaknesses
Table 159. Credence MedSystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 160. Credence MedSystems, Inc. Major Business
Table 161. Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 162. Credence MedSystems, Inc. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Credence MedSystems, Inc. Recent Developments/Updates
Table 164. Credence MedSystems, Inc. Competitive Strengths & Weaknesses
Table 165. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Major Business
Table 167. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 168. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Recent Developments/Updates
Table 170. Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Wuxi NEST Life Sciences Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Wuxi NEST Life Sciences Co., Ltd. Major Business
Table 173. Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 174. Wuxi NEST Life Sciences Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Wuxi NEST Life Sciences Co., Ltd. Recent Developments/Updates
Table 176. Wuxi NEST Life Sciences Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Jiangsu Wanhai Medical Instrument Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 178. Jiangsu Wanhai Medical Instrument Co., Ltd. Major Business
Table 179. Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Product and Services
Table 180. Jiangsu Wanhai Medical Instrument Co., Ltd. Prefilled Injection Delivery Devices for GLP-1 Drugs Production (Unit), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Jiangsu Wanhai Medical Instrument Co., Ltd. Recent Developments/Updates
Table 182. Jiangsu Wanhai Medical Instrument Co., Ltd. Competitive Strengths & Weaknesses
Table 183. Global Key Players of Prefilled Injection Delivery Devices for GLP-1 Drugs Upstream (Raw Materials)
Table 184. Global Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Customers
Table 185. Prefilled Injection Delivery Devices for GLP-1 Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Prefilled Injection Delivery Devices for GLP-1 Drugs Picture
Figure 2. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 5. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 9. Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 10. China Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 11. Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 12. Prefilled Injection Delivery Devices for GLP-1 Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 15. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 17. China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 18. Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 19. Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 20. South Korea Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 21. ASEAN Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 22. India Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 23. Producer Shipments of Prefilled Injection Delivery Devices for GLP-1 Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Prefilled Injection Delivery Devices for GLP-1 Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Prefilled Injection Delivery Devices for GLP-1 Drugs Markets in 2025
Figure 26. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 32. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Type in 2025
Figure 34. Prefilled Pen Injector
Figure 35. Autoinjector
Figure 36. Prefillable Syringe
Figure 37. Cartridge based Pen System
Figure 38. Safety Injection Component
Figure 39. Others
Figure 40. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Type (2021-2032)
Figure 41. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Type (2021-2032)
Figure 42. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format, (USD Million), 2021 & 2025 & 2032
Figure 44. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Dose Format in 2025
Figure 45. Single dose Device
Figure 46. Multi dose Device
Figure 47. Others
Figure 48. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Dose Format (2021-2032)
Figure 49. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Dose Format (2021-2032)
Figure 50. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2032) & (US$/Unit)
Figure 51. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication, (USD Million), 2021 & 2025 & 2032
Figure 52. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Indication in 2025
Figure 53. Type 2 Diabetes Treatment
Figure 54. Obesity Treatment
Figure 55. Cardiometabolic Risk Management
Figure 56. Other Metabolic Disorders
Figure 57. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Indication (2021-2032)
Figure 58. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Indication (2021-2032)
Figure 59. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2032) & (US$/Unit)
Figure 60. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Application in 2025
Figure 62. Hospital
Figure 63. Pharmacy
Figure 64. Others
Figure 65. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Application (2021-2032)
Figure 66. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Application (2021-2032)
Figure 67. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 68. Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Chain
Figure 69. Prefilled Injection Delivery Devices for GLP-1 Drugs Procurement Model
Figure 70. Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Model
Figure 71. Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Prefilled Injection Delivery Devices for GLP-1 Drugs Picture
Figure 2. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 5. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 9. Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 10. China Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 11. Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Production (2021-2032) & (Unit)
Figure 12. Prefilled Injection Delivery Devices for GLP-1 Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 15. World Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 17. China Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 18. Europe Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 19. Japan Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 20. South Korea Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 21. ASEAN Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 22. India Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption (2021-2032) & (Unit)
Figure 23. Producer Shipments of Prefilled Injection Delivery Devices for GLP-1 Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Prefilled Injection Delivery Devices for GLP-1 Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Prefilled Injection Delivery Devices for GLP-1 Drugs Markets in 2025
Figure 26. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prefilled Injection Delivery Devices for GLP-1 Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share 2025
Figure 32. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Type in 2025
Figure 34. Prefilled Pen Injector
Figure 35. Autoinjector
Figure 36. Prefillable Syringe
Figure 37. Cartridge based Pen System
Figure 38. Safety Injection Component
Figure 39. Others
Figure 40. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Type (2021-2032)
Figure 41. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Type (2021-2032)
Figure 42. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Dose Format, (USD Million), 2021 & 2025 & 2032
Figure 44. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Dose Format in 2025
Figure 45. Single dose Device
Figure 46. Multi dose Device
Figure 47. Others
Figure 48. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Dose Format (2021-2032)
Figure 49. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Dose Format (2021-2032)
Figure 50. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Dose Format (2021-2032) & (US$/Unit)
Figure 51. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Indication, (USD Million), 2021 & 2025 & 2032
Figure 52. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Indication in 2025
Figure 53. Type 2 Diabetes Treatment
Figure 54. Obesity Treatment
Figure 55. Cardiometabolic Risk Management
Figure 56. Other Metabolic Disorders
Figure 57. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Indication (2021-2032)
Figure 58. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Indication (2021-2032)
Figure 59. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Indication (2021-2032) & (US$/Unit)
Figure 60. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Application in 2025
Figure 62. Hospital
Figure 63. Pharmacy
Figure 64. Others
Figure 65. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Market Share by Application (2021-2032)
Figure 66. World Prefilled Injection Delivery Devices for GLP-1 Drugs Production Value Market Share by Application (2021-2032)
Figure 67. World Prefilled Injection Delivery Devices for GLP-1 Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 68. Prefilled Injection Delivery Devices for GLP-1 Drugs Industry Chain
Figure 69. Prefilled Injection Delivery Devices for GLP-1 Drugs Procurement Model
Figure 70. Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Model
Figure 71. Prefilled Injection Delivery Devices for GLP-1 Drugs Sales Channels, Direct Sales, and Distribution
Figure 72. Methodology
Figure 73. Research Process and Data Source
